DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma

De-tao Yin1, Wenxun Wu, Mingchuang Li

  • 1Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, People's Republic of China. detaoyin@zzu.edu.cn

Insights

Dickkopf homolog 3 (DKK3) gene downregulation in thyroid cancer is linked to promoter methylation. DKK3 acts as a tumor suppressor, with its methylation correlating to increased tumor aggressiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Dickkopf homolog 3 (DKK3) gene expression is reduced in various human cancers, suggesting a tumor suppressor function.
  • The specific role and regulation of DKK3 in thyroid cancer remain largely unexamined.

Purpose of the Study:

  • To investigate the association between DKK3 promoter methylation and its inactivation in papillary thyroid carcinoma (PTC).
  • To explore the relationship between DKK3 expression, promoter methylation, and tumor behaviors in PTC.

Main Methods:

  • Utilized methylation-specific PCR and RT-PCR to analyze DKK3 promoter methylation and mRNA expression in PTC tissues and matched normal samples.
  • Correlated DKK3 methylation and expression levels with clinicopathological characteristics of PTC.
  • Treated PTC cell line TPC-1 with a demethylating agent (5-azaC) to assess functional impact on DKK3 expression.

Main Results:

  • DKK3 mRNA expression was significantly lower in PTC tissues (44.9%) compared to normal thyroid tissues (100%).
  • DKK3 promoter methylation was detected in 38.8% of PTC samples, contrasting with 0% in normal tissues.
  • An inverse correlation was observed between DKK3 promoter methylation and its mRNA expression, as well as between DKK3 expression and aggressive PTC features (high TNM stage, lymph node metastasis).
  • DKK3 promoter hypermethylation positively correlated with tumor pathological aggressiveness.

Conclusions:

  • DKK3 functions as a potential tumor suppressor gene in thyroid cancer.
  • Aberrant promoter methylation is a key mechanism driving DKK3 downregulation in PTC.
  • DKK3 methylation may contribute to PTC tumorigenesis and disease progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...